Connecting the Oncology Community in Oklahoma

OSCO serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry.

News

Merck’s WELIREG™ (belzutifan) Receives FDA Approval

Merck has informed OSCO that WELIREG™ (belzutifan) 40-mg tablets has received FDA approval. WELIREG is indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. SELECTED SAFETY INFORMATION WARNING: EMBRYO-FETAL […]

Read More...

Natera’s Signatera® Selected for US Trial

Natera is proud to announce that Signatera has been selected for NRG Oncology pivotal CIRCULATE – US trial for patients with resected stage II or III colon cancer. CIRCULATE -US (NRG-G1008) is a prospective, multi-center, randomized clinical trial that aims to establish a new standard of care (SOC) for these patients using Signatera MRD to guide […]

Read More...

U.S. FDA Grants BRUKINSA® (Zanubrutinib) Approval in Waldenström’s Macroglob

BeiGene Ltd. Announces a new approval for BRUKINSA (zanubrutinib) in Waldenström’s macroglobulinaemia, including the updated Prescribing Information. For more information: Download BRUKINSA Full Prescribing Information Download BRUKINSA Patient Information BRUKINSA WEBSITE

Read More...

Upcoming Events

Join the Oklahoma Society of Clinical Oncology, Inc. for our fall meeting on November 6, 2021, ASCO Direct™, an officially licensed program of the American Society of Clinical Oncology®.  This virtual meeting will break down the most clinically relevant abstracts from ASCO’s annual symposium, allowing attendees to engage with the latest strategies in oncology education.  All exhibitors will have access to the full meeting application and will be able to view all the virtual sessions.  Details of the virtual meeting are:

Learn More »

Become a Sponsor

Your company can sponsor OSCO and the work we do by becoming a corporate member today! For more information or to sign up, contact Kathy Musson, OSCO Executive Director at kmussonokc@gmail.com or by phone at 405-850-8334.

See More »

Who We Are

Who We Are

The Oklahoma Society of Clinical Oncology (OSCO) is Oklahoma’s only professional organization that represents all those in oncology. Our membership works to advance the sciences of hematology and oncology and its sub-specialties, and to improve services to the public by studying the socio-economic aspects of the practice of our members.

Learn More »